S&P 500   4,585.31 (+0.79%)
DOW   36,120.53 (+0.18%)
QQQ   390.47 (+1.41%)
AAPL   194.14 (+0.95%)
MSFT   370.96 (+0.59%)
META   326.52 (+2.86%)
GOOGL   136.81 (+5.22%)
AMZN   146.63 (+1.46%)
TSLA   241.85 (+1.04%)
NVDA   464.82 (+2.15%)
NIO   7.49 (-3.35%)
BABA   72.35 (+1.20%)
AMD   127.92 (+9.50%)
T   17.08 (+0.83%)
F   10.83 (+1.31%)
MU   73.59 (+0.63%)
CGC   0.72 (+3.03%)
GE   119.04 (-0.64%)
DIS   92.36 (+0.94%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.47 (-1.78%)
XOM   98.33 (-0.79%)
S&P 500   4,585.31 (+0.79%)
DOW   36,120.53 (+0.18%)
QQQ   390.47 (+1.41%)
AAPL   194.14 (+0.95%)
MSFT   370.96 (+0.59%)
META   326.52 (+2.86%)
GOOGL   136.81 (+5.22%)
AMZN   146.63 (+1.46%)
TSLA   241.85 (+1.04%)
NVDA   464.82 (+2.15%)
NIO   7.49 (-3.35%)
BABA   72.35 (+1.20%)
AMD   127.92 (+9.50%)
T   17.08 (+0.83%)
F   10.83 (+1.31%)
MU   73.59 (+0.63%)
CGC   0.72 (+3.03%)
GE   119.04 (-0.64%)
DIS   92.36 (+0.94%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.47 (-1.78%)
XOM   98.33 (-0.79%)
S&P 500   4,585.31 (+0.79%)
DOW   36,120.53 (+0.18%)
QQQ   390.47 (+1.41%)
AAPL   194.14 (+0.95%)
MSFT   370.96 (+0.59%)
META   326.52 (+2.86%)
GOOGL   136.81 (+5.22%)
AMZN   146.63 (+1.46%)
TSLA   241.85 (+1.04%)
NVDA   464.82 (+2.15%)
NIO   7.49 (-3.35%)
BABA   72.35 (+1.20%)
AMD   127.92 (+9.50%)
T   17.08 (+0.83%)
F   10.83 (+1.31%)
MU   73.59 (+0.63%)
CGC   0.72 (+3.03%)
GE   119.04 (-0.64%)
DIS   92.36 (+0.94%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.47 (-1.78%)
XOM   98.33 (-0.79%)
S&P 500   4,585.31 (+0.79%)
DOW   36,120.53 (+0.18%)
QQQ   390.47 (+1.41%)
AAPL   194.14 (+0.95%)
MSFT   370.96 (+0.59%)
META   326.52 (+2.86%)
GOOGL   136.81 (+5.22%)
AMZN   146.63 (+1.46%)
TSLA   241.85 (+1.04%)
NVDA   464.82 (+2.15%)
NIO   7.49 (-3.35%)
BABA   72.35 (+1.20%)
AMD   127.92 (+9.50%)
T   17.08 (+0.83%)
F   10.83 (+1.31%)
MU   73.59 (+0.63%)
CGC   0.72 (+3.03%)
GE   119.04 (-0.64%)
DIS   92.36 (+0.94%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.47 (-1.78%)
XOM   98.33 (-0.79%)

Cannara Biotech Stock Price, News & Analysis (OTCMKTS:CNBTF)

$0.61
0.00 (0.00%)
(As of 12/6/2023 ET)
Today's Range
$0.61
▼
$0.61
50-Day Range
$0.60
▼
$0.76
52-Week Range
$0.08
▼
$0.20
Volume
N/A
Average Volume
33,127 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlines

CNBTF Stock Price History

CNBTF Stock News Headlines

December 1, 2023 | cnbc.com
Why it's important to open a credit card at age 18
December 1, 2023 | cnbc.com
Here are the best virtual credit cards of 2023
December 7, 2023 | Autonomix (Ad)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
November 19, 2023 | cnbc.com
Dan Buettner
November 19, 2023 | cnbc.com
Power Lunch
November 18, 2023 | cnbc.com
Money market account vs. High-yield savings account: What’s the difference and which one should you choose?
October 8, 2023 | cnbc.com
Hugh Son
October 1, 2023 | cnbc.com
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
December 7, 2023 | Autonomix (Ad)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
September 27, 2023 | cnbc.com
If your business needs a revolving credit line, consider these 4 lenders
September 14, 2023 | cnbc.com
Liz Knueven
September 14, 2023 | cnbc.com
Elizabeth Gravier
September 8, 2023 | cnbc.com
Jasmin Suknanan
September 8, 2023 | cnbc.com
Limited time offer: Get Walmart+ for 50% off and save shipping, gas and more
August 31, 2023 | cnbc.com
Benji Stawski
August 29, 2023 | cnbc.com
Pia Singh
August 28, 2023 | cnbc.com
What is a point-of-sale loan and are they worth it?
August 12, 2023 | cnbc.com
China's Corporate Spy War
August 3, 2023 | cnbc.com
CNBC's Last Call Podcast
August 2, 2023 | cnbc.com
Trump told by special counsel he is criminal target in Jan. 6 probe
August 1, 2023 | cnbc.com
The best easy-to-earn credit card sign-up bonuses for low spenders
July 29, 2023 | cnbc.com
How to use a microloan to help your small business grow
July 27, 2023 | benzinga.com
Cannara Biotech Q3 FY23 Net Revenue Grows 57% YoY, What About Adjusted EBITDA?
July 12, 2023 | cnbc.com
Morgan Chittum
July 12, 2023 | cnbc.com
Taylor Swift, FTX and how investors can avoid potential scams
June 30, 2023 | cnbc.com
This 51-year-old pays $725 a month to live in a 'tiny home on wheels’ in someone's backyard—take a look inside
June 30, 2023 | cnbc.com
Ari Weisbard
See More Headlines
Receive CNBTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cannara Biotech and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
N/A
Sub-Industry
N/A
Sector
N/A
Current Symbol
OTCMKTS:CNBTF
CUSIP
N/A
CIK
N/A
Web
cannara.ca
Phone
N/A
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Zohar Krivorot (Age 42)
    Founder, Pres, CEO & Director
  • Mr. Lennie Ryer CPA (Age 58)
    CPA, CA, CFE, VP of Fin. & CFO
  • Mr. Evan Morris
    Chief Operating Officer
  • Ms. Julia Bouvet
    Chief of Staff














CNBTF Stock Analysis - Frequently Asked Questions

How have CNBTF shares performed in 2023?

Cannara Biotech's stock was trading at $0.0733 at the beginning of the year. Since then, CNBTF shares have increased by 737.0% and is now trading at $0.6133.
View the best growth stocks for 2023 here.

How do I buy shares of Cannara Biotech?

Shares of CNBTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:CNBTF) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -